文献速递主动脉疾病

开窗EVAR患者中腔内动脉瘤封堵技术的解剖适用性

Anatomical Applicability of Endovascular Aneurysm Sealing Techniques in a Consecutive Cohort of Fenestrated Endovascular Aneurysm Repairs.
PubMed 文献 · J Endovasc Ther · 2017-09-12

结果显示EVAS/ChEVAS技术可行于56例(93.3%),但仅23.2%被推荐,主要顾虑为血栓比率相关的迁移风险;EVAS/ChEVAS的近端锚定区更远端、涉及目标血管更少、装置成本为FEVAR的66%。

要点

  • FEVAR患者中EVAS/ChEVAS技术可行率93.3%,但仅23.2%被推荐。
  • EVAS/ChEVAS近端锚定区更远端(8区 vs 7区,p<0.001)。
  • EVAS/ChEVAS涉及目标血管更少(中位2 vs 3,p<0.001),装置成本为FEVAR的66%。

核心结论

  • 在本机构FEVAR患者中EVAS技术可行于大多数,但当前仅推荐23.2%。

研究设计与样本

  • 术前CTA匿名后由两名有超过40例ChEVAS经验的医师盲法评估并商定EVAS/ChEVAS计划。
  • 主要结局为EVAS/ChEVAS技术可行百分比,次要结局包括锚定区、目标血管数和装置成本比较。

主要发现

  • EVAS/ChEVAS技术可行于56例(93.3%)FEVAR患者。
  • EVAS/ChEVAS近端锚定区显著更远端(8区 vs 7区,p<0.001)。
  • EVAS/ChEVAS涉及目标血管数更少(中位2 vs 3,p<0.001)。
  • EVAS/ChEVAS装置成本为FEVAR装置的66%。
  • 计划者因观察到管腔血栓比率相关的迁移风险,当前不推荐43例(76.8%)行EVAS。

关键数值与推荐

  • 中位动脉瘤直径62.0 mm(四分位距59.3,69.0)。

临床怎么用

  • 在FEVAR候选患者中可评估EVAS/ChEVAS解剖适用性,但需谨慎权衡管腔血栓比率相关的迁移风险。
  • EVAS/ChEVAS可能减少目标血管数并降低装置成本,但锚定区更远端。

局限性

  • 计划者评估基于匿名CTA,未报告实际EVAS/ChEVAS实施结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine how many endovascular aneurysm sealing (EVAS) procedures with/without off-label use of chimneys (ChEVAS) could have been performed in a cohort of patients who had undergone fenestrated endovascular aneurysm repair (FEVAR). METHODS: Sixty patients (median age 76.3 years; 54 men) who underwent FEVAR in our institution between 2013 and 2015 were selected for the study. The median aneurysm diameter was 62.0 mm (interquartile range 59.3, 69.0). Preoperative computed tomography angiograms (CTA) were anonymized and sent to 2 physicians with experience of more than 40 ChEVAS interventions. These ChEVAS planners were blinded to the study purpose and asked to agree upon an EVAS/ChEVAS plan. The primary outcome was the percentage of the FEVAR patients in whom an EVAS/ChEVAS was technically possible. The secondary outcomes were a comparison of seal zones, number of target vessels, and device cost. RESULTS: An EVAS-based intervention would have been technically possible in 56 (93.3%) of the FEVAR patients. The median proximal aortic seal zone was significantly more distal in the EVAS/ChEVAS procedures vs the FEVAR cases (zone 8 vs zone 7, p<0.001) and fewer target vessels were involved (median 2 vs 3, p<0.001). The cost of the EVAS/ChEVAS device was 66% of the FEVAR device. Planners would not currently advocate an EVAS-based intervention in 43 (76.8%) of these 56 patients due to concerns regarding the risk of migration associated with the lumen thrombus ratios observed. CONCLUSION: EVAS is technically feasible in the majority of patients undergoing FEVAR in our institution but currently advocated in only 23.2%. The seal zone was more distal, fewer target vessels were involved, and the device cost was lower in the planned EVAS/ChEVAS interventions.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Roy IN, Gharib M, Zerwes S, et al. Anatomical Applicability of Endovascular Aneurysm Sealing Techniques in a Consecutive Cohort of Fenestrated Endovascular Aneurysm Repairs. J Endovasc Ther. 2017. PMID: 28895448. doi:10.1177/1526602817728069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。